Screener
Omnicell OMCL Q2 2026 earnings
Reported July 30, 2026 · Before market open
Revenue$312.2MBeat by $2.0M
EPS$0.94Beat by $0.47
Revenue estimate$310.2M
EPS estimate$0.47
“We believe our performance reflects the strength of our diversified business model, the resilience of demand across our core medication management solutions, and our ongoing focus on operational discipline. We also remain confident in the long-term opportunities we see ahead of us and continue to see strong customer interest in solutions that are built to help health systems improve efficiency, safety, and workforce productivity.”
Next report
Oct 29, 2026 (In 3 weeks)Revenue estimate$304.4M
EPS estimate$0.42
Valuation & ratios
Segments
Versus estimates
Revenue
Diluted EPS
FAQ
- When did Omnicell report Q2 2026 earnings?
- Omnicell (OMCL) reported Q2 2026 earnings on July 30, 2026 before market open.
- What were Omnicell's Q2 2026 revenue and EPS?
- Omnicell reported revenue of $312.2M and eps of $0.94 for Q2 2026.
- Did Omnicell beat estimates in Q2 2026?
- Revenue beat the consensus estimate of $310.2M by $2.0M. EPS beat the consensus estimate of $0.47 by $0.47.
- How did Omnicell's Q2 2026 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 7.4% from $290.6M a year earlier and eps grew 108.9% from $0.45.
- Where can I find Omnicell's Q2 2026 SEC filings?
- You can read the 8-K earnings release (0000926326-26-000019) and the 10-Q periodic report (0000926326-26-000022) directly on SEC EDGAR. The filing index links above go to sec.gov.
